Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers October 23, 2014
Pharmacy Choice - News - Front Page Healthcare News - October 23, 2014

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

10/23/14 - Carl Domino, Patrick Murphy face off in heated debate for 18th District congressional seat [Treasure Coast Newspapers, Stuart, Fla.]
Oct. 22 PALM BEACH GARDENS Carl Domino came out swinging Tuesday night, taking aim at Democratic incumbent Patrick Murphy on everything from the Affordable Care Act to amnesty for undocumented immigrants to All Aboard Florida. And while the Republican challenger for the 18th District congressional seat tried to land more zingers during the one-
10/23/14 - Colorado Springs Health Partners gets new owner; patients unlikely to see changes [The Gazette (Colorado Springs, Colo.)]
Oct. 22 Denver- based kidney care giant DaVita HealthCare Partners Inc. announced Wednesday it has acquired Colorado Springs Health Partners, the largest health care practice in Colorado Springs a deal that could change the face of local health care. Offices: 11 in Colorado Springs area. History: Total Renal Care was nearly bankrupt where Thiry
10/23/14 - Harvoni Approved For The Treatment Of Chronic Hepatitis C; TapImmune Provides Update on PolyStart? Vaccine Platform
FDA announced October 10, 2014 that Gilead Sciences Harvoni product was approved for the treatment of chronic hepatitis C, genotype 1 infection in adults. Sofosbuvir was approved by the FDA under the trade name Sovaldi in December 2013. Harvoni is a product of Gilead Sciences, based in Foster City, California.======================== TapIm
10/23/14 - Pomona Valley Hospital earns national recognition for cardiac services [Inland Valley Daily Bulletin, Calif.]
Denver- based Healthgrades named Pomona Valley Hospital Medical Center among America's 100 Best Hospitals for cardiac care and for coronary intervention in addition to bestowing the hospital a Cardiac Surgery Excellence Award, according to the Healthgrades website. "It is truly an honor to be the only hospital in Southern California recognized by.
10/22/14 - "Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2014" Is Now Available at Fast Market Research
Fast Market Research recommends " Arbor Pharmaceuticals, LLC.- Product Pipeline Review- 2014" from Global Markets Direct, now availableBoston, MA 10/22/2014 Global Markets Direct's,' Arbor Pharmaceuticals, LLC.- Product Pipeline Review- 2014', provides an overview of the Arbor Pharmaceuticals, LLC.' s pharmaceutical research and development f
10/22/14 - 'Liberians Won't Be Used As Guinea Pigs' for Ebola Trial Drugs Not Approved
The Liberia Medicines& Health Products Regulatory Authority has strongly warned pharmaceutical companies and others, who are trying to bring in "Ebola drugs/medicines," for trial purposes, that Liberians won't be used as Guinea pigs. LMHRA, which released a statement yesterday, is the Government of Liberia's arm that has the statutory mandate to re
10/22/14 - Accelera Innovations, Inc. Announces Purchase Agreement of SCI Home Health Inc (d/b/a Advance Lifecare Home Health, LLC)
On October 7, 2014, Accelera Innovations, Inc. announced that they have closed on the acquisition of SCI Home Health, Inc, this decision was based on SCI's growth rate of 30 to 40% annually. SCI is 100% Medicare certified, and is engaged in the business of providing home health care services. The programs offered are Speech Therapy, Occupational
10/22/14 - Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin
DUBLIN and BOSTON, Oct. 22, 2014/ PRNewswire/ Actavis plc, a leading global specialty pharmaceutical company, and Rhythm, a biopharmaceutical company, today announced that Actavis has been granted an exclusive option to acquire Rhythm's wholly owned subsidiary, Rhythm Health, Inc., which is developing relamorelin, a peptide ghrelin agonist, for t
10/22/14 - Alkermes New Drug Application for Aripiprazole Lauroxil for Treatment of Schizophrenia Accepted for Filing by U.S. FDA
Alkermes plc today announced that the U.S. Food and Drug Administration has accepted for filing the New Drug Application for aripiprazole lauroxil, the company s investigational, novel, once-monthly injectable atypical antipsychotic for the treatment of schizophrenia. Under the Prescription Drug User Fee Act, the FDA s target action date for
10/22/14 - AVACEN Medical Announces FDA Clearance of First Medical Device with Internal Game Mode
AVACEN Medical announced today that its AVACEN 100 Class II medical device received 510 OTC clearance by the U.S. Food and Drug Administration. This clearance allows the AVACEN 100 to be marketed over the Internet for: the temporary relief of joint pain associated with arthritis; muscle spasms; and minor strains and sprains. In' Game Mode,' the t
10/22/14 - bioMerieux Works With FDA For Approval Of Its Ebola Screening Test [Global Data Point]
bioMerieux spokeswoman Suzanne Jones said that since the FilmArray system was solely developed for environmental surveillance, it is necessary for the company to demonstrate the US Food and Drug Administration evidence that the test could be used clinically.&# x0D;.
10/22/14 - Bristol-Myers Squibb Statement about Asunaprevir in the U.S.
By a News Reporter-Staff News Editor at Biotech Week Given the rapidly evolving hepatitis C treatment landscape in the U.S., Bristol-Myers Squibb has decided that it will not pursue U.S. Food and Drug Administration approval of the dual regimen of daclatasvir and asunaprevir for the treatment of HCV genotype 1 b patients in the United States and
10/22/14 - Carl Domino, Patrick Murphy face off in heated debate for 18th District congressional seat [Treasure Coast Newspapers, Stuart, Fla.]
Oct. 22 PALM BEACH GARDENS Carl Domino came out swinging Tuesday night, taking aim at Democratic incumbent Patrick Murphy on everything from the Affordable Care Act to amnesty for undocumented immigrants to All Aboard Florida. And while the Republican challenger for the 18th District congressional seat tried to land more zingers during the one-
10/22/14 - Centric Medical? Announces FDA Clearance of TARSA-LINK? Internal Fixation System for Foot and Ankle
Centric Medical, a new division of Life Spine, Inc., which focuses on developing surgical implants for the treatment of distal extremity pathology, announced today that the U.S. Food and Drug Administration has given 510 marketing clearance to its TARSA-LINK system, for internal bone fixation of fractures, fusions, and osteotomies in the foot and a
10/22/14 - CHAMPS' Megan Coriell Discusses How Survivorship Care Plans + Coding = Reimbursement
In 2012, the Commission on Cancer released their new Cancer Program Standards: Ensuring Patient-Centered Care. These codes may be helpful when seeking reimbursement for survivorship care plans:? Healthcare Common Procedure Coding System codes S0353 and S0354 are not accepted by Medicare, but are generally accepted by private payers.? New Curren
10/22/14 - CNPR Certification Becomes an Industry Standard as The Need for Qualified Pharmaceutical Sales Representatives Increases in 2014
The United States is the world's largest market for pharmaceuticals and is the world leader in biopharmaceutical research. The United States also spends almost $1,000 per person per year on pharmaceuticals. That's around 40 percent more than the next highest spender, Canada, and more than twice as much as than countries like France and Germany spen
10/22/14 - CTRC doctor wins $1.6 million FDA orphan grant to treat deadly brain tumors
By a News Reporter-Staff News Editor at Biotech Week A researcher at the Cancer Therapy& Research Center is the leader on a study receiving a special $1.62 million orphan disease grant from the Food& Drug Administration. The FDA's four-year grant will allow Andrew Brenner, M.D., Ph.D. to continue the study how the drug TH-302 may help people with
10/22/14 - Cytori Therapeutics Receives FDA Approval to Resume ATHENA Trial Enrollment
Cytori Therapeutics, Inc. has received notification from the FDA that Cytori has provided additional information sufficient to support continuation of enrollment in its ATHENA cardiovascular trials. The FDA has agreed that the submitted data and protocol amendments support the fact that there are no subject protection concerns that preclude...
10/22/14 - Dallas Clinic: New Viberect Device Successfully Treats Erectile Dysfunction
The Dallas Anti-Aging Institute announces the availability of the new FDA- certified Viberect medical device that has achieved a high rate of success in treating men who have lost penile sexual function due to prostate cancer, spinal chord injury, surgery, age, and other causes. Kambiz Tajkarimi, urologist and developer of the Viberect device
10/22/14 - DaVita HealthCare Partners to Acquire Colorado Springs Health Partners
DaVita HealthCare Partners Inc., a leading provider of population health and kidney care services, today announced that HealthCare Partners has entered into an agreement to acquire Colorado Springs Health Partners, a multi-specialty medical group with more than 100 physicians at 11 locations throughout the Pikes Peak region. "By combining a nati
10/22/14 - EMA Ready to Start Assessment of Ebola Vaccines and Treatments As Soon As Data Are Made Available
The European Union's Medicines Agency issued the following news:. During the past months, the European Medicines Agency has put in place a system to give the best possible scientific advice to companies that are currently developing possible vaccines and/or treatments to fight Ebola virus disease. The March 2014 outbreak of Ebola virus disease in W
10/22/14 - FDA approves Auxilium's Xiaflex to treat Dupuytren's Contracture [EMBIN (Emerging Markets Business Information News]
The US Food and Drug Administration has approved a supplemental Biologics Application for Auxilium Pharmaceuticals' Xiaflex to treat up to two Dupuytren's contracture joints in the same hand during a single treatment visit. Xiaflex is approved in the US, EU, Canada and Australia to treat adult DC patients with a palpable cord. Auxilium Pharmaceutic
10/22/14 - FDA approves more manufacturing facilities for Halozyme's Hylenex recombinant production [EMBIN (Emerging Markets Business Information News]
Halozyme Therapeutics has received approval from the US Food and Drug Administration for new contract manufacturing facilities used in the production of Hylenex recombinant. The approval allows the use of the Cook Pharmica manufacturing facility in Bloomington, Indiana for the production of bulk rHuPH20, the active ingredient used in Hylenex, and t
10/22/14 - FDA Grants Clearance to Proceed with Clinical Study - New Drug Candidate from Vivolux Could Overcome Drug Resistance
By a News Reporter-Staff News Editor at Biotech Week Vivolux, a pharmaceutical company specialized in cancer treatment, announced that the FDA has granted clearance to proceed with VLX1570 to clinical phase I/II for treatment against relapsed and/or refractory multiple myeloma. The clinical study will be conducted in collaboration with the Memori
10/22/14 - Ferring Pharmaceuticals Inc. Receives FDA Approval For New Cranberry Flavor Of PREPOPIK Sodium Picosulfate, Magnesium Oxide, And Anhydrous Citric...
Ferring Pharmaceuticals Inc. Receives FDA Approval For New Cranberry Flavor Of PREPOPIK Sodium Picosulfate, Magnesium Oxide, And Anhydrous Citric Acid. To offer an alternative choice in bowel preparation, Ferring Pharmaceuticals Inc. will introduce a new cranberry flavor option of PREPOPIK in January 2015. Gastroenterology business unit at Ferri
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2014 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

The Diversion of Controlled Substances and the Law
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comPharmacyPages.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415